| Title: | Genetic variability of immune checkpoints in asbestos-related diseases |
|---|
| Authors: | ID Zeljković Vitas, Irma (Author)
ID Goričar, Katja (Author)
ID Blagus, Tanja (Author)
ID Franko, Alenka (Author)
ID Kovač, Viljem (Author)
ID Dolžan, Vita (Author) |
|---|
| Files: |  PDF - Presentation file, download (492,94 KB)
MD5: 80F692F5DD886CF949B62ADFA8EBF23A
 URL - Source URL, visit https://reference-global.com/article/10.2478/raon-2026-0035
|
|---|
| Language: | English |
|---|
| Typology: | 1.01 - Original Scientific Article |
|---|
| Organization: |  OI - Institute of Oncology
 DRO - Association of Radiology and Oncology
|
|---|
| Abstract: | Background Asbestos exposure is associated with asbestos-related diseases such as pleural plaques, asbestosis, lung cancer, malignant mesothelioma (MM), as well as several other types of cancer. Although the exact mechanism underlying the development of asbestos-related diseases is not yet fully understood, the immune system may play an important role. Immune checkpoints such as programmed cell death receptor 1 (PD-1), programmed cell death ligand-1 (PD-L1), and cytotoxic T lymphocyte-associated protein 4 (CTLA-4) regulate immune responses and are crucial for maintaining immune tolerance, while defects in these mechanisms can lead to the development of cancer. The aim of present study was to investigate the association of polymorphisms in the immune checkpoint genes for PD-1 (PDCD1), PD-L1 (CD274), and CTLA-4 (CTLA4) with the risk of asbestos-related diseases. Subjects and methods We conducted a retrospective case-control study. The cases included individuals with asbestosis or pleural plaques and MM patients. The controls were asbestos-exposed subjects who did not develop asbestos-related diseases. All subjects were genotyped for PDCD1 (rs2227982, rs222798, rs10204525), CD274 (rs2297136, rs4143815, rs4742098) and CTLA4 (rs5742909, rs4553808, rs231775) polymorphisms using competitive allele-specific PCR. Statistical analysis was performed using logistic regression. Results Our study showed that the CTLA4 rs4553808 polymorphism was associated with a decreased risk of asbestosrelated diseases (OR = 0.34, 95% CI = 0.15-0.74, P = 0.007). Homozygous carriers of polymorphic rs4553808 G allele had a lower risk of developing pleural plaques as well as MM compared to the control group (OR = 0.28, 95% CI = 0.11-0.68, P = 0.01, and OR = 0.38, 95% CI = 0.16 -0.93, P = 0.03, respectively). However, carriers of polymorphic CTLA4 rs231775 GG genotype had a higher risk of developing MM compared to the group of subjects with pleural plaques (OR = 1.79, 95% CI = 1.10-2.89, P = 0.02). The other investigated polymorphisms were not associated with any of the asbestos-related diseases. Conclusions CTLA4 polymorphisms may play a role in the susceptibility for asbestos-related diseases. Our results may contribute to a better understanding of the pathogenesis and progression of asbestos-related diseases. |
|---|
| Keywords: | asbestos, malignant mesothelioma, immune checkpoints, single nucleotide polymorphism |
|---|
| Publication status: | Published |
|---|
| Publication version: | Version of Record |
|---|
| Publication date: | 01.06.2026 |
|---|
| Publisher: | Association of Radiology and Oncology |
|---|
| Year of publishing: | 2026 |
|---|
| Number of pages: | str. 271-281 |
|---|
| Numbering: | Vol. 60, no. 2 |
|---|
| Source: | Ljubljana |
|---|
| PID: | 20.500.12556/DiRROS-31215  |
|---|
| UDC: | 616-006 |
|---|
| ISSN on article: | 1318-2099 |
|---|
| DOI: | 10.2478/raon-2026-0035 |
|---|
| COBISS.SI-ID: | 284688387 |
|---|
| Copyright: | by Authors |
|---|
| Note: | Soavtorji: Katja Goricar, Tanja Blagus, Alenka Franko, Viljem Kovac and Vita Dolzan;
|
|---|
| Publication date in DiRROS: | 22.07.2026 |
|---|
| Views: | 212 |
|---|
| Downloads: | 106 |
|---|
| Metadata: |    |
|---|
|
:
|
Copy citation |
|---|
| | | | Share: |  |
|---|
Hover the mouse pointer over a document title to show the abstract or click
on the title to get all document metadata. |
